Immunoadjuvant Properties of Oncolytic Schwarz Measles Virus
|
|
- Ethelbert Perkins
- 6 years ago
- Views:
Transcription
1 Immunoadjuvant Properties of Oncolytic Schwarz Measles Virus Dr Jean-François Fonteneau Institut de Recherche en Santé de l Université de Nantes INSERM UMR892, CNRS UMR6299 Nantes, France
2 Anti-tumor Virotherapy using oncolytic virus Infection apoptosis Activation of the immune system Oncolytic virus Infection Tumor cells Healthy cells Ideal replicating oncolytic virus: (Russell SJ, Nature biotechnol, 2012 Vacchelli E et al, Oncoimmunology, 2013) - Infects exclusively or preferentially tumor cells - Kills efficiently tumor cells (apoptosis) - No toxicity (genetically stable, minor side effects) - High viral concentration production capability - Induction or stimulation of an anti-tumor immune response.
3 Measles virus vaccine () based anti-tumoral virotherapy Hémagglutinine (H) Protéine de Fusion (F) Protéine de Matrice (M) Protéine L Phosphoprotéine (P) ARN + Nucléoprotéine (N) Double membrane lipidique Guillerme JB et al, Biology, 2013 Measles virus vaccine, Schwarz strain (): Dr Frédéric Tangy (Viral genomics and Vaccination laboratory, Pasteur Institut, Paris) - Enveloped, non-segmented, negative-sense, single-stranded RNA (ssrna) paramyxovirus of the genus Morbillivirus - Attenuated replicating vaccine strain of measles virus: Schwarz (MMR vaccine) - Targets CD46, complement regulatory protein (wt targets CD150/SLAM) - CD46 is expressed at low level by healthy cells - CD46 is often found overexpressed on tumor cells - antiviral pathway defects are often found in tumor cells - Spontaneously oncolytic: - Lymphoma, glioma, breast, ovary, prostate (Russell SJ, Mayo Clinic, USA) - MPM, colon and lung adenocarcinoma (Gauvrit A et al, Cancer Research, 2008; Boisgerault N et al, Biomed Res Int, 2013)
4 infection of Malignant Pleural Mesothelioma tumor cells Video : infection of meso13 by -egfp (enhanced green fluorescent protein)
5 Limited infection of healthy mesothelial cells Video : healthy mesothelial cells exposed to -egfp
6 Activation of the immune system by infected tumor cells? Tumor cells Apoptosis Danger signals DAMPs? PAMPs? Immature DC Cross presentation to Mature DC? CD8+ T Lymphocytes (CTL)? Myeloid DC? Plasmacytoid DC?
7 Activation of monocyte derived DC (Mo-DC) and tumor antigen cross-priming by infected tumor cells Mo-DC activation Tumor antigen cross-priming 80 CD83 IL-12p % CD83 + cells IL-12p70 (pg/ml) CD86 IL Median Fluorescence Intensity IL-10 (pg/ml) IFN-α DCi / Poly I:C alone Meso13 M6 IFN-α DCi / Poly I:C alone Meso13 M6 Gauvrit et al, Cancer Research, 2008
8 Plasmacytoid Dendritic Cells (pdc) Expression of TLR7 et TLR9 => specialized in recognition of viral nucleic acids ARNsb Producehugequantitiesof Type I IFN (-αand β) in response to virus Antigen cross presentation in human: HIV(Hoeffel, G,.Immunity, 2007) (Crozat, K., J Exp Med, 2010) Influenza(Lui, G., PLoS One, 2009) Antigencross presentationin mice: Cross-tolérance(Goubier, A., Dubois, B., Immunity, 2008) OVA (Mouries, J., Blood, 2008) One of the targetof imiquimod(r837, TLR7 ligand) in the treatment of basal cell carcinoma with Aldara. IFN-α Production and tumor antigen cross-presentation by pdc exposed to infected tumor cells?
9 pdc are not infected by Schwarz Video : pdc exposed to -egfp
10 infected tumor cells induce maturation of plasmacytoid DC FSC BDCA4 CD83 CD86 CD40 CD83 CD86 9 % 92.4 % 4,27 130, % 5,13 10 SSC CD123 IL3 +IL3 M18 M18 UV Meso13 Meso13 UV A549 A549 UV IL3 +IL3 M18 M18 UV IL3 IL ** *** *** ** *** % Positive Cells Meso13 Meso13 UV A549 A549 UV * R-MFI Meso13 Meso13 UV % 5,99 60 CD * % 12, % 5, IL3 +IL3 M18 M18 UV Meso13 Meso13 UV A549 A549 UV R-MFI
11 infected tumor cells are internalized by plasmacytoid DC Mo-DC pdc 4 C 37 C 4 C 37 C HLA-DR Alexa568 PKH-67 MERGE M18 UV pdc + M18 A549 pdc + A549 UV PKH67 PKH67 HLA-DR BDCA-4
12 activates pdc IFN-α production by TLR IFN-α (ng/ml) IL3 IL3 + M18 M18 UV A549 A549 UV pd DC IFN-α(ng/ml) α IL-3 0 0,1 0, ,1 0, ,1 0,5 1 IRS661 IRS661 IRS661 IL-3 + *10 CpG-A M18 (TLR-9) IRS661: TLR7inhibitor
13 probably activates pdc via TLR7 in early endosome CpG-A (TLR9) CpG-B (TLR9) -> High IFN-α -> Low IFN-α -> Low costimulation (CD80, CD86) -> High costimulation (CD80, CD86) Kerkmann M et al, J Immunol, > Low inflammatory molecules secretion (IL-8) -> High inflammatory molecules secretion (IL-8) Early endosome Late endosome Honda K et al, Nature, 2005 Guiducci C et al, J Exp Med, 2006 IRF7 pathway NF-κB pathway Sadaka C et al, Blood, 2009 Kubo-Murai M et al, Blood, 2008 HIV (TLR7) (TLR7/TLR8) CpG-B (TLR9) O brien M et al, J Clin Invest, 2011 (TLR7) (TLR7/TLR8) Guillerme JB et al, clin cancer Res, 2013
14 NYESO-1 cross-presentation by pdc exposed to infected tumor cells NYESO-1 (NYESO-1 / RPLPO)* M 18 A549 NI UV M18 : HLA-A*0201-, NYESO-1+ A549 : HLA-A*0201-, NYESO-1- pdc : HLA-A*0201+, NYESO-1- M : HLA-A*0201/NYESO-1( ) specific CD8+ T cell clone
15 NYESO-1 cross-presentation by pdc exposed to infected tumor cells LT only pdc+ LT 0.1% 0.1% CD8 CD8 IFN-γ IFN-γ LT + pdc 0.1µM NYESO-1 [ ] 1µM NYESO-1 [ ] 10.8% 87.5% UV 6.5% 0.2% M18 0.8% 0.2% A % of IFNγ+ T CD8+ cells IFN-γ IFN-γ LT - pdc M18 M18 UV 0.3% 0.1% CD8 CD8 CD8 CD8 LT only (n=5) pdc + LT (n=6) pdc 0.1 µm NYESO-1 (n=3) pdc + M18 (n=6) pdc + M18 UV(n=5) IFN-γ IFN-γ
16 NYESO-1 cross-presentation by pdc and Mo-DC exposed to infected tumor cells Ø NYESO-1 [ ] (10µM) Mo-DC pdc 0.6% 68% 0.3% 79.6% Mo - DC Cross- presentation LT only Mo-DCi Mo-DCm + 0,1µM NY-ESO-1 Mo-DC + M18 Mo-DC + M18UV % of IFN γ + T CD8+ cells 11.7% M18 HLA-A*0201 neg /NY-ESO-1 pos 0.16% M18 UV HLA-A*0201 neg /NY-ESO-1 pos CD8 CD8 IFN-y IFN-y 8.15% 0.4% 20 pdc cross-presentation 10 0 LT only (n=5) pdc + LT (n=6) pdc 0.1 µm NYESO-1 (n=3) pdc + M18 (n=6) pdc + M18 UV(n=5) % of IFNγ+ T CD8+ cells
17 NYESO-1 cross-presentation by Mo-DC is increased by TNF-α/IFN-γ Mo-DC Mo-DC 0,5 Mo-DC + pep 1µM 95,1 Mo-DC + IFN-γ + TNF-α Mo-DC + % CD8 + /IFNγ + cells M18 M18 UV 10,0 22,7 7,0 0 0,5 2,2 0,9 Mo-DC (-) IF FN-γ TNF-α (-) IF FN-γ TNF-α (-) IF FN-γ TNF-α (-) IF FN-γ TNF-α M18 M18 UV M18 M18 UV (+) Mo-DC (-) Mo-DC M18 (-) IFN-γ+ TNF-α 1,2 4,9 1,3 Deauvieau F et al, Int J Cancer, 2014 M18 UV 0,5 2,3 0,7
18 Conclusions Blood myeloid DC? CD1c+ DC? CD141+ DC? Gauvrit A et al, Cancer Research, 2008 Prefered Infection Limited infection Tumor cells (CD46 high ) Healthy cells (CD46 low ) Apoptosis -infected Tumor cells Phagocytosis Maturation ->Cross-priming of TAA-specific CD8+ T cell response TAA PAMP? DAMP (HSP70, gp96) (IFN-α, IFN-β, HMGB1, IL-6 IL-8) Phagocytosis Immature Mo-DC TAA PAMP ( Single-strand RNA) DAMP? Immature plasmacytoid DC Maturation Mature Mo-DC Mature plasmacytoid DC ->Cross-presentation of TAA to specific CD8+ T cells Cross-priming? ->Production of a large quantity of IFN-α Guillerme JB et al, Clinical Cancer Research, 2013 Donnelly OG et al, Gene Ther, 2013
19 Funding Collaborations Plateforme de dévelopement et de transfert à la clinique (CHU Nantes) : Delphine Coulais, ingénieur Clarisse Panterne, ingénieur Service de pneumologie du CHU de Nantes Laurent Cellerin, Christine Sagan Antoine Magnan Service de pneumologie du CHU de Lille Arnaud Scherpereel Team (Inserm U892,Nantes) Marc Grégoire, INSERM Christophe Blanquart, CNRS Daniel Pouliquen, INSERM Jean-François Fonteneau, INSERM Nicolas Boisgerault Jean-Baptiste Guillerme Carole Achard, Ferdaous Allagui Iza Denis Clarisse Panterne Sophie Deshayes Institut Pasteur, Viral genomics and Vaccination laboratory Frédéric Tangy Mariana Mesel-Lemoine Centre de Recherche en cancérologie de Lyon Jenny Valladeau Christophe Caux
Measles virus vaccine induces oncolysis of tumor cells and activates immune responses.
Measles virus vaccine induces oncolysis of tumor cells and activates immune responses. Marc Grégoire*, J.-F. Fonteneau, N. Boisgerault, J.-B. Guillerme and F. Tangy. * INSERM, Nantes, F-44, France. Pasteur
More informationIsorce Nathalie, Testoni B., Luangsay S., Locatelli M., Zannetti C., Henry T., Hasan U., Zoulim F., Durantel D.
Activité antivirale de différents interférons (IFNs) et cytokines proinflammatoires dans des modèles pertinents d hépatocytes infectés par le virus de l hépatite B (HBV) Isorce Nathalie, Testoni B., Luangsay
More informationTowards an HIV Cure Pre-Conference Symposium 20 & 21 July 2012
Towards an HIV Cure Pre-Conference Symposium 20 & 21 July 2012 Your logo Natural control of HIV infection is associated with an isotype switched IgG antibody response to HIV Gag antigens in patients with
More informationAntibodies for human plasmacytoïd dendritic cells studies Dendritics SAS, 60 avenue Rockefeller, F Lyon
Antibodies for human plasmacytoïd dendritic cells studies Dendritics SAS, 60 avenue Rockefeller, F-69008 Lyon www.dendritics.net Human plasmacytoïd dendritic cells (PDCs) are considered the main sentinels
More informationIntracellular MHC class II molecules promote TLR-triggered innate. immune responses by maintaining Btk activation
Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining Btk activation Xingguang Liu, Zhenzhen Zhan, Dong Li, Li Xu, Feng Ma, Peng Zhang, Hangping Yao and Xuetao
More informationInnate Immunity. Chapter 3. Connection Between Innate and Adaptive Immunity. Know Differences and Provide Examples. Antimicrobial peptide psoriasin
Chapter Know Differences and Provide Examples Innate Immunity kin and Epithelial Barriers Antimicrobial peptide psoriasin -Activity against Gram (-) E. coli Connection Between Innate and Adaptive Immunity
More informationReplicating measles-shiv vaccine induces long term preservation of central memory CD4 cells in the gut of macaques challenged with SHIV89.
Replicating measles-shiv vaccine induces long term preservation of central memory CD4 cells in the gut of macaques challenged with SHIV89.6P Frédéric Tangy Viral Genomics and Vaccination Laboratory Measles
More informationAntigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS
1 Antigen Presentation and T Lymphocyte Activation Abul K. Abbas UCSF FOCiS 2 Lecture outline Dendritic cells and antigen presentation The role of the MHC T cell activation Costimulation, the B7:CD28 family
More informationVpu Reduces Innate Sensing of HIV-1-infected cells by PDCs via a BST2-dependent process
Vpu Reduces Innate Sensing of HIV-1-infected cells by PDCs via a -dependent process Mariana G. Bego, Édouard Bérubé-Côté, Johanne Mercier, and Éric A. Cohen Institut de Recherches Cliniques de Montréal.
More information1. TLR. TLR Toll-like receptors. Toll Toll-like receptor, TLR TLR TLR TLR. type I TLR TLR. Toll
54pp.145 152 2004 1. TLR T B TLR Toll-like receptors TLR TLR I IFN TLR T B B T Toll NF- B 1996 565-0871 3-1 TEL 06-6879-8303 FAX 06-6879-8305 E-mail uemattsu@biken.osaka-u.ac.jp Toll Toll-like receptor,
More informationInnate immunity. Abul K. Abbas University of California San Francisco. FOCiS
1 Innate immunity Abul K. Abbas University of California San Francisco FOCiS 2 Lecture outline Components of innate immunity Recognition of microbes and dead cells Toll Like Receptors NOD Like Receptors/Inflammasome
More informationCancer immunotherapy with oncolytic viruses: more than just lysis
Cancer immunotherapy with oncolytic viruses: more than just lysis Dmitriy Zamarin MD PhD Assistant Attending, Immune Therapeutics Center Memorial Sloan-Kettering Cancer Center New York, NY BCAN Think Tank
More informationACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT
ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS Choompone Sakonwasun, MD (Hons), FRCPT Types of Adaptive Immunity Types of T Cell-mediated Immune Reactions CTLs = cytotoxic T lymphocytes
More informationCOURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16
COURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16 Tumor Immunology M. Nagarkatti Teaching Objectives: Introduction to Cancer Immunology Know the antigens expressed by cancer cells Understand
More informationHerpes virus reactivation in brain-injured patients : The IBIS virus study
Herpes virus reactivation in brain-injured patients : role and mechanisms of CD4 T cell defects. The IBIS virus study Antoine Roquilly University Hospital of Nantes, France UPRES 386 Medical University
More informationRole of Innate Immunity in Hepatitis B Virus Infection Adam J. Gehring, Ph.D.
Role of Innate Immunity in Hepatitis B Virus Infection Adam J. Gehring, Ph.D. Biology Lead Toronto Centre for Liver Disease Toronto General Hospital Research Institute University Health Network (UHN) HBV
More informationGeneral Overview of Immunology. Kimberly S. Schluns, Ph.D. Associate Professor Department of Immunology UT MD Anderson Cancer Center
General Overview of Immunology Kimberly S. Schluns, Ph.D. Associate Professor Department of Immunology UT MD Anderson Cancer Center Objectives Describe differences between innate and adaptive immune responses
More informationInstitute t of Experimental Immunology University of Bonn, Germany
How T cells recognize antigen Christian Kurts Institute t of Experimental Immunology University of Bonn, Germany When do T cells recognize antigen? Antigen uptake Activation phase 1st recognition Effector
More informationDendritic Cell Based Immunotherapy for Cancer. Edgar G. Engleman, M.D.
Dendritic Cell Based Immunotherapy for Cancer Edgar G. Engleman, M.D. Two main DC subsets Myeloid (mydc) Derived from monocytes Capture/process/present Ag to T cells Activate NK cells and B cells Plasmacytoid
More information2. Innate immunity 2013
1 Innate Immune Responses 3 Innate immunity Abul K. Abbas University of California San Francisco The initial responses to: 1. Microbes: essential early mechanisms to prevent, control, or eliminate infection;
More information10th International Rotavirus Symposium Bangkok, Thailand
Rotavirus Host Range Restriction and Innate Immunity: Mechanisms of Vaccine Attenuation Harry Greenberg MD Stanford University 10th International Rotavirus Symposium Bangkok, Thailand 09/19/12 B dsrna
More informationCrucial role for human Toll-like receptor 4 in the development of contact allergy to nickel
Supplementary Figures 1-8 Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel Marc Schmidt 1,2, Badrinarayanan Raghavan 1,2, Verena Müller 1,2, Thomas Vogl 3, György
More informationIntrinsic cellular defenses against virus infection
Intrinsic cellular defenses against virus infection Detection of virus infection Host cell response to virus infection Interferons: structure and synthesis Induction of antiviral activity Viral defenses
More informationInnate Immunity. Hathairat Thananchai, DPhil Department of Microbiology Faculty of Medicine Chiang Mai University 2 August 2016
Innate Immunity Hathairat Thananchai, DPhil Department of Microbiology Faculty of Medicine Chiang Mai University 2 August 2016 Objectives: Explain how innate immune system recognizes foreign substances
More informationJPEMS Nantes, Basic Immunology INNATE IMMUNITY
JPEMS Nantes, 2014- Basic Immunology INNATE IMMUNITY Teacher: Pr. Régis Josien, Laboratoire d Immunologie and INSERM U1064, CHU Nantes Regis.Josien@univ-nantes.fr 1 Contents 1. General features and specificity
More informationThe Role of Plasmacytoid Dendritic Cells in Psoriasis
6 ème Journée du Groupe de Recherche sur le Psoriasis Paris, 9 novembre 2012 The Role of Plasmacytoid Dendritic Cells in Psoriasis Dr Curdin Conrad, PD & MER Department of Dermatology Psoriasis: Clinical
More informationCationic Liposome-DNA Complexes as Immunomodulators and Vaccine Adjuvants
Cationic Liposome-DNA Complexes as Immunomodulators and Vaccine Adjuvants September 29, 28 Platform Technology Proprietary Cationic Lipid-DNA Complexes Cationic/Neutral Lipid + DNA = JVRS-1 JVRS-1 + Antigen
More informationImmune surveillance hypothesis (Macfarlane Burnet, 1950s)
TUMOR-IMMUNITÄT A.K. Abbas, A.H. Lichtman, S. Pillai (6th edition, 2007) Cellular and Molecular Immunology Saunders Elsevier Chapter 17, immunity to tumors Immune surveillance hypothesis (Macfarlane Burnet,
More informationVaccines. Prof. Lana E. Kandalaft. Director Centre of Experimental Therapeutics, Deparment of Oncology, UNIL CHUV
Vaccines Prof. Lana E. Kandalaft Director Centre of Experimental Therapeutics, Deparment of Oncology, UNIL CHUV Assisant Professor, Ludwig Cancer Reaserch Branch Adjunct Assistant Professor, University
More informationDendritic cells in cancer immunotherapy Aimin Jiang
Dendritic cells in cancer immunotherapy Aimin Jiang Feb. 11, 2014 Dendritic cells at the interface of innate and adaptive immune responses Dendritic cells: initiators of adaptive immune responses Dendritic
More informationStructure and Function of Antigen Recognition Molecules
MICR2209 Structure and Function of Antigen Recognition Molecules Dr Allison Imrie allison.imrie@uwa.edu.au 1 Synopsis: In this lecture we will examine the major receptors used by cells of the innate and
More informationT-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:
Interactions between innate immunity & adaptive immunity What happens to T cells after they leave the thymus? Naïve T cells exit the thymus and enter the bloodstream. If they remain in the bloodstream,
More informationT-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:
Interactions between innate immunity & adaptive immunity What happens to T cells after they leave the thymus? Naïve T cells exit the thymus and enter the bloodstream. If they remain in the bloodstream,
More informationImmunity to Viruses. Patricia Fitzgerald-Bocarsly September 25, 2008
Immunity to Viruses Patricia Fitzgerald-Bocarsly September 25, 2008 The Immune System Deals with a Huge Range of Pathogens Roitt, 2003 Immune Responses to Viruses Viruses are dependent on the host cell
More informationImmunology. T-Lymphocytes. 16. Oktober 2014, Ruhr-Universität Bochum Karin Peters,
Immunology T-Lymphocytes 16. Oktober 2014, Ruhr-Universität Bochum Karin Peters, karin.peters@rub.de The role of T-effector cells in the immune response against microbes cellular immunity humoral immunity
More informationBiomarqueurs et rejet chronique pulmonaire: Résultats de l Initiative de la Cohorte de Greffe Pulmonaire (COLT)
Biomarqueurs et rejet chronique pulmonaire: Résultats de l Initiative de la Cohorte de Greffe Pulmonaire (COLT) Antoine Magnan, Adrien Tissot, Aurore Foureau, Maxim Durand, Carole Brosseau, PierreJoseph
More informationTCR, MHC and coreceptors
Cooperation In Immune Responses Antigen processing how peptides get into MHC Antigen processing involves the intracellular proteolytic generation of MHC binding proteins Protein antigens may be processed
More informationNewly Recognized Components of the Innate Immune System
Newly Recognized Components of the Innate Immune System NOD Proteins: Intracellular Peptidoglycan Sensors NOD-1 NOD-2 Nod Protein LRR; Ligand Recognition CARD RICK I-κB p50 p65 NF-κB Polymorphisms in Nod-2
More informationSupplementary Figure 1. Double-staining immunofluorescence analysis of invasive colon and breast cancers. Specimens from invasive ductal breast
Supplementary Figure 1. Double-staining immunofluorescence analysis of invasive colon and breast cancers. Specimens from invasive ductal breast carcinoma (a) and colon adenocarcinoma (b) were staining
More informationLAMPvax DNA Vaccines as Immunotherapy for Cancer - Three Case Studies
LAMPvax DNA Vaccines as Immunotherapy for Cancer - Three Case Studies Cancer immunotherapy has emerged as a clinically validated tool for fighting certain kinds of cancers. These therapeutic cancer vaccines
More informationEbola virus crisis. Prof. Viktor Volchkov. Molecular basis of viral pathogenicity
Ebola virus crisis Prof. Viktor Volchkov Molecular basis of viral pathogenicity International Centre for Research in Infectiology (CIRI), INSERM Claude Bernard University Lyon-1, Lyon, France viktor.volchkov@inserm.fr
More informationInnate Immunity. Connection Between Innate and Adaptive Immunity. Know Differences and Provide Examples Chapter 3. Antimicrobial peptide psoriasin
Know Differences and Provide Examples Chapter * Innate Immunity * kin and Epithelial Barriers * Antimicrobial peptide psoriasin -Activity against Gram (-) E. coli Connection Between Innate and Adaptive
More informationLecture on Innate Immunity and Inflammation
Lecture on Innate Immunity and Inflammation Evolutionary View Epithelial barriers to infection Four main types of innate recognition molecules:tlrs, CLRs, NLRs, RLRs NF-κB, the master transcriptional regulator
More information1. The scavenger receptor, CD36, functions as a coreceptor for which TLR? a. TLR ½ b. TLR 3 c. TLR 4 d. TLR 2/6
Allergy and Immunology Review Corner: Cellular and Molecular Immunology, 8th Edition By Abul K. Abbas, MBBS, Andrew H. H. Lichtman, MD, PhD and Shiv Pillai, MBBS, PhD. Chapter 4 (pages 62-74): Innate Immunity
More informationAutoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens
Autoimmunity Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens Autoimmune disease can be caused to primary defects in B cells, T cells and possibly
More informationIOM Immunization Safety Review 11/12/2001. Immunological Competition and the Infant Immune Response to Vaccines
IOM Immunization Safety Review 11/12/2001 Immunological Competition and the Infant Immune Response to Vaccines Richard Insel University of Rochester Goals Neonatal and Infant Immune System Broad Effects
More informationVaccine Delivery and TLR Ligands Influence the Quality of T cell Responses in NHP. Robert A. Seder, M.D. Vaccine Research Center NIAID, NIH
Vaccine Delivery and TLR Ligands Influence the Quality of T cell Responses in NHP Robert A. Seder, M.D. Vaccine Research Center NIAID, NIH Vaccines Against HIV, Malaria and Tuberculosis Will Require Neutralizing
More informationIdentifying Biologic Targets to Attenuate or Eliminate Asthma Exacerbations
Identifying Biologic Targets to Attenuate or Eliminate Exacerbations exacerbations are a major cause of disease morbidity and costs. For both children and adults, viral respiratory infections are the major
More informationTumor Immunology. Tumor (latin) = swelling
Tumor Immunology Tumor (latin) = swelling benign tumor malignant tumor Tumor immunology : the study of the types of antigens that are expressed by tumors how the immune system recognizes and responds to
More informationRichard S. Kornbluth, M.D., Ph.D.
Treatment of established tumors with peritumoral injections of CD40 ligand (CD40L), CpG, poly(i:c), and extracellular ATP in murine models Richard S. Kornbluth, M.D., Ph.D. Disclosure: Richard Kornbluth
More informationLa risposta immune all infezione da virus ebola. Chiara Agrati, PhD
La risposta immune all infezione da virus ebola Chiara Agrati, PhD Pathogenetic mechanisms This virus infection is able to: - disable the immune system, preventing an effective protective immune response
More informationJustus Hallam Iowa State University. Iowa State University Capstones, Theses and Dissertations. Graduate Theses and Dissertations
Graduate Theses and Dissertations Iowa State University Capstones, Theses and Dissertations 2013 Exercise-mediated changes in plasmacytoid dendritic cell production of IFNα and the effects of moderate
More informationSensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response
/, Vol. 6, No. 42 Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response Carole Achard 1,2,3, Nicolas Boisgerault 1,2,3, Tiphaine Delaunay
More informationTumors arise from accumulated genetic mutations. Tumor Immunology (Cancer)
Tumor Immunology (Cancer) Tumors arise from accumulated genetic mutations Robert Beatty MCB150 Mutations Usually have >6 mutations in both activation/growth factors and tumor suppressor genes. Types of
More informationEffector Mechanisms of Cell-Mediated Immunity
Effector Mechanisms of Cell-Mediated Immunity Dr. Julia Rempel Section of Hepatology 789-3825 jdrempel@cc.umanitoba.ca 804D JBRC Topics: I. Types of Cell-Mediated Immunity II. Migration of Effector T Lymphocytes
More informationBihong Zhao, M.D, Ph.D Department of Pathology
Bihong Zhao, M.D, Ph.D Department of Pathology 04-28-2009 Is tumor self or non-self? How are tumor antigens generated? What are they? How does immune system respond? Introduction Tumor Antigens/Categories
More informationInduction of Innate Immune Responses in HVTN 071: a Trial using the MRKAd5 gag/pol/nef Vaccine from the Step Study
Induction of Innate Immune Responses in HVTN 71: a Trial using the MRKAd5 gag/pol/nef Vaccine from the Step Study Erica Andersen-Nissen Vaccine and Infectious Disease Institute Fred Hutchinson Cancer Research
More informationScott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION
Scott Abrams, Ph.D. Professor of Oncology, x4375 scott.abrams@roswellpark.org Kuby Immunology SEVENTH EDITION CHAPTER 11 T-Cell Activation, Differentiation, and Memory Copyright 2013 by W. H. Freeman and
More information08/02/59. Tumor Immunotherapy. Development of Tumor Vaccines. Types of Tumor Vaccines. Immunotherapy w/ Cytokine Gene-Transfected Tumor Cells
Tumor Immunotherapy Autologous virus Inactivation Inactivated virus Lymphopheresis Culture? Monocyte s Dendritic cells Immunization Autologous vaccine Development of Tumor Vaccines Types of Tumor Vaccines
More informationLecture on Innate Immunity and Inflammation. Innate Immunity: An Evolutionary View
Lecture on Innate Immunity and Inflammation Evolutionary View Epithelial barriers to infection Four main types of innate recognition molecules:tlrs, CLRs, NLRs, RLRs NF-κB, the master transcriptional regulator
More information1. Overview of Adaptive Immunity
Chapter 17A: Adaptive Immunity Part I 1. Overview of Adaptive Immunity 2. T and B Cell Production 3. Antigens & Antigen Presentation 4. Helper T cells 1. Overview of Adaptive Immunity The Nature of Adaptive
More informationCYTOKINE RECEPTORS AND SIGNAL TRANSDUCTION
CYTOKINE RECEPTORS AND SIGNAL TRANSDUCTION What is Cytokine? Secreted popypeptide (protein) involved in cell-to-cell signaling. Acts in paracrine or autocrine fashion through specific cellular receptors.
More informationOncolytic Viruses as a Potential Approach to Eliminate the HIV Reservoir
Oncolytic Viruses as a Potential Approach to Eliminate the HIV Reservoir Costiniuk CT, Côté SC, Al-Ghazawi FM, Carrasco-Medina L,Young CD, & Angel JB University of Ottawa, November 12 th, 2012 HIV Reservoirs
More informationImmunotherapy in Lung Cancer - TLR9 as a therapeutic target -
Immunotherapy in Lung Cancer - TLR9 as a therapeutic target - Wilfried Eberhardt,, MD Head of Outpatient Unit, Dept. of Internal Medicine (Cancer Research) West German Cancer Centre Essen University Hospital
More informationMeasuring Dendritic Cells
Measuring Dendritic Cells A.D. Donnenberg, V.S. Donnenberg UNIVERSITY of PITTSBURGH CANCER INSTITUTE CCS Longbeach 10_04 Measuring DC Rare event detection The basics of DC measurement Applications Cancer
More informationOncolytic virus strategy
Oncolytic viruses Oncolytic virus strategy normal tumor NO replication replication survival lysis Oncolytic virus strategy Mechanisms of tumor selectivity of several, some of them naturally, oncolytic
More informationTD-BF01: Innate immunity to microorganisms
TD-BF01: Innate immunity to microorganisms I. Toll receptors (adapted from Takeuchi, O. et al. (1999) Immunity 11:443; Kawai, T. et al. (1999) Immunity 11:115; Hemmi, H. et al. (2000) Nature 408:740; Muzio,
More informationCell-mediated Immunity
Cellular & Molecular Immunology Cell-mediated Immunity Nicholas M. Ponzio, Ph.D. Department of Pathology & Laboratory Medicine April 6, 2009 Today s Presentation: Overview Cellular Interactions In Humoral
More information7/6/2009. The study of the immune system and of diseases that occur as a result of inappropriate or inadequate actions of the immune system.
Diseases of Immunity 2009 CL Davis General Pathology Paul W. Snyder, DVM, PhD Purdue University Acknowledgements Pathologic Basis of Veterinary Disease, 4 th Ed Veterinary Immunology, An Introduction 8
More informationAGAINST VIRAL INFECTIONS. Identify the types of immunity involve in the mechanisms of protection against viral infections.
LECTURE: 02 Title: THE IMMUNOLOGICAL PROTECTIVE MECHANISMS AGAINST VIRAL INFECTIONS LEARNING OBJECTIVES: The student should be able to: Identify the types of immunity involve in the mechanisms of protection
More informationImmune Regulation and Tolerance
Immune Regulation and Tolerance Immunoregulation: A balance between activation and suppression of effector cells to achieve an efficient immune response without damaging the host. Activation (immunity)
More informationRadiation Therapy as an Immunomodulator
Radiation Therapy as an Immunomodulator Yvonne Mowery, MD, PhD February 20, 2017 Tumor/Immune System Balance Kalbasi, JCI 2013 UNC-Duke-NC State-Wake Forest Spring 2017 2 RT Can Shift Balance Toward Elimination
More informationInnate Immunity. Hathairat Thananchai, DPhil Department of Microbiology Faculty of Medicine Chiang Mai University 25 July 2017
Innate Immunity Hathairat Thananchai, DPhil Department of Microbiology Faculty of Medicine Chiang Mai University 25 July 2017 Objectives: Explain how innate immune system recognizes foreign substances
More informationCancer Immunotherapy: Active Immunization Approaches
Cancer Immunotherapy: Active Immunization Approaches Willem W. Overwijk, PhD Department of Melanoma Medical Oncology MD Anderson Cancer Center Houston, TX, USA Disclosures No relevant financial relationships
More informationTherapeutic Immunization with Autologous DC Pulsed with Autologous Inactivated HIV-1 Infected Apoptotic Cells
Therapeutic Immunization with Autologous DC Pulsed with Autologous Inactivated HIV-1 Infected Apoptotic Cells Sharon A. Riddler, MD, MPH University of Pittsburgh May 2008 Slide 1 HIV and DC Vaccines During
More informationa Beckman Coulter Life Sciences: White Paper
a Beckman Coulter Life Sciences: White Paper An 8-color DuraClone IM panel for detection of Human blood dendritic cells by flow cytometry Nathalie Dupas 1, Snehita Sattiraju 2, Neha Girish 2, Murthy Pendyala
More informationRole of Innate Immunity in Control of Adaptive Immunity
Role of Innate Immunity in Control of Adaptive Immunity Innate Immunity The burden of pathogen sensing is placed on the innate immune system Danger hypothesis Missing Self Based on the detection of molecular
More informationAutoimmune Diseases. Betsy Kirchner CNP The Cleveland Clinic
Autoimmune Diseases Betsy Kirchner CNP The Cleveland Clinic Disclosures (financial) No relevant disclosures Learning Objectives Explain the pathophysiology of autoimmune disease Discuss safe administration
More informationHIV Immunopathogenesis. Modeling the Immune System May 2, 2007
HIV Immunopathogenesis Modeling the Immune System May 2, 2007 Question 1 : Explain how HIV infects the host Zafer Iscan Yuanjian Wang Zufferey Abhishek Garg How does HIV infect the host? HIV infection
More informationT Cell Effector Mechanisms I: B cell Help & DTH
T Cell Effector Mechanisms I: B cell Help & DTH Ned Braunstein, MD The Major T Cell Subsets p56 lck + T cells γ δ ε ζ ζ p56 lck CD8+ T cells γ δ ε ζ ζ Cα Cβ Vα Vβ CD3 CD8 Cα Cβ Vα Vβ CD3 MHC II peptide
More informationSynergistic combinations of targeted immunotherapy to combat cancer
Synergistic combinations of targeted immunotherapy to combat cancer Myung Ah Lee, M.D., Ph. D Division of Medical Oncology, Hepato-biliary pancreatic cancer center Seoul St. Mary s hospital, The Catholic
More informationSupplemental Figure 1. IL-3 blockade with Fab CSL362 depletes plasmacytoid dendritic cells (pdcs), but not basophils, at higher doses.
Supplemental Figure 1. IL-3 blockade with Fab CSL362 depletes plasmacytoid dendritic cells (pdcs), but not basophils, at higher doses. Percentage of viable (A) pdcs (Sytox Blue-, Lin1-, HLADR+, BDCA2++)
More informationÉtude de la coopération entre les cellules dendritiques et les lymphocytes T dans les allergies aux produits chimiques FPH42
Étude de la coopération entre les cellules dendritiques et les lymphocytes T dans les allergies aux produits chimiques FPH42 Dr Diane Antonios-Gholam PharmD, PhD Laboratoire de Toxicologie Clinique et
More information核酸アジュバントによる 樹状細胞活性化の分子メカニズム
ワクチンフォーラム 2010 September 14, 2010 核酸アジュバントによる 樹状細胞活性化の分子メカニズム 理研 免疫 アレルギー科学総合研究センター生体防御研究チーム改正恒康 Homepage:http://www.riken.jp/hosdef/ index.html Nucleic acid-sensing receptors Virus Plasma membrane Endosome
More informationThe next steps for effective cancer immunotherapy and viral vaccines. Peter Selby FACP(UK)
The next steps for effective cancer immunotherapy and viral vaccines Peter Selby FACP(UK) Richard Alan Steve Sasha Matt Nav Vile Melcher Griffin Zougman Bentham Vasudev Adel Nick Gemma Liz Samson Hornigold
More informationImpact of TLR7/8 Triggering on HIV Pathogenesis
University Hospital Zurich u Division of Infectious Diseases and Hospital Epidemiology Impact of TLR7/8 Triggering on HIV Pathogenesis Roberto F. Speck, MD Hallmark of HIV-Infection is the Progressive
More informationBIT 120. Copy of Cancer/HIV Lecture
BIT 120 Copy of Cancer/HIV Lecture Cancer DEFINITION Any abnormal growth of cells that has malignant potential i.e.. Leukemia Uncontrolled mitosis in WBC Genetic disease caused by an accumulation of mutations
More informationCytokines (II) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:
Cytokines (II) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Learning Objectives By the end of this lecture you will be able to: 1 Understand the physiological
More informationHerpesviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics
Herpesviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Enveloped icosahedral capsid (T=16), diameter 125 nm Diameter of enveloped virion 200 nm Capsid
More informationLAG-3: Validation Of Next Generation Checkpoint Pathways
LAG-3: Validation Of Next Generation Checkpoint Pathways Frédéric Triebel, CO/CMO Immune Checkpoint Modulation & Combination Therapies April 13, 2016 London, UK. 1 AX:PRR; NADAQ:PBMD Notice: Forward Looking
More informationThe Major Histocompatibility Complex (MHC)
The Major Histocompatibility Complex (MHC) An introduction to adaptive immune system before we discuss MHC B cells The main cells of adaptive immune system are: -B cells -T cells B cells: Recognize antigens
More informationTumor Immunology. Wirsma Arif Harahap Surgical Oncology Consultant
Tumor Immunology Wirsma Arif Harahap Surgical Oncology Consultant 1) Immune responses that develop to cancer cells 2) Escape of cancer cells 3) Therapies: clinical and experimental Cancer cells can be
More informationBases for Immunotherapy in Multiple Myeloma
Bases for Immunotherapy in Multiple Myeloma Paola Neri, MD, PhD Associate Professor of Medicine University of Calgary, Arnie Charbonneau Cancer Institute Disclosures Paola Neri MD, PhD Grants/research
More informationSupporting Information
Supporting Information Sui et al..7/pnas.997 Pre-CLP CM9 LA9 SL Tat# Pol Vif % Tetramer + CD + CD + Vac+IL- +IL- Vac Fig. S. Frequencies of six different CD + CD + Mamu-A*-tetramer + cells were measured
More informationVIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON
VIRUSES Biology Applications Control David R. Harper GS Garland Science Taylor & Francis Group NEW YORK AND LONDON vii Chapter 1 Virus Structure and 2.2 VIRUS MORPHOLOGY 26 Infection 1 2.3 VIRAL CLASSIFICATION
More informationViruses. CLS 212: Medical Microbiology Miss Zeina Alkudmani
Viruses CLS 212: Medical Microbiology Miss Zeina Alkudmani History Through the 1800s, many scientists discovered that something smaller than bacteria could cause disease and they called it virion (Latin
More informationwell for 2 h at rt. Each dot represents an individual mouse and bar is the mean ±
Supplementary data: Control DC Blimp-1 ko DC 8 6 4 2-2 IL-1β p=.5 medium 8 6 4 2 IL-2 Medium p=.16 8 6 4 2 IL-6 medium p=.3 5 4 3 2 1-1 medium IL-1 n.s. 25 2 15 1 5 IL-12(p7) p=.15 5 IFNγ p=.65 4 3 2 1
More informationIMO-8400, a novel TLR7, TLR8 and TLR9 antagonist, psoriasis
IMO-8400, a novel TLR7, TLR8 and TLR9 antagonist, inhibits disease development in mouse models of psoriasis Weiwen e Ja Jiang, Fu-Gang Zhu, Dong Yu, Ekambar R. Kandimalla, a a, Nicola La Monica, and Sudhir
More informationPractical Solution: presentation to cytotoxic T cells. How dendritic cells present antigen. How dendritic cells present antigen
Christian Kurts Institutes of Molecular Medicine and Experimental Immunology University of Bonn, Germany - presentation and (CTL) activation - I presentation and CD4 + T cell (Th cell) activation Different
More informationAllergy and Immunology Review Corner: Chapter 13 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD.
Allergy and Immunology Review Corner: Chapter 13 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD. Chapter 13: Mechanisms of Immunity to Viral Disease Prepared by
More information